Akerna (NASDAQ:KERN) reported quarterly sales of $6.10 million which missed the analyst consensus estimate of $7.04 million by 13.35 percent. This is a 48.38 percent increase over sales of $4.11 million the same period last year.
Pfizer, Global Blood Therapeutics In Advanced Talks For $5B Buyout Deal: Report
Pfizer Inc (NYSE: PFE) is reportedly in advanced talks to buy Global Blood Therapeutics Inc (NASDAQ: GBT) for about $5 billion, bolster its portfolio and pipeline.
